1. Metabolic Enzyme/Protease
  2. HIV Protease

HIV Protease

HIV Protease is a retroviral aspartyl protease that is essential for the life-cycle of HIV, the retrovirus that causes AIDS. HIV protease cleaves newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV protease, HIV virions remain uninfectious. Thus, mutation of HIV protease's active site or inhibition of its activity disrupts HIV’s ability to replicate and infect additional cells, making HIV protease inhibition the subject of considerable pharmaceutical research. Mutations enable HIV to avoid treatments that involve only one drug, so there is growing use of multiple-drug therapies in which both a protease inhibitor AND a reverse transcript inhibitor are combined.

HIV Protease Related Products (16):

Cat. No. Product Name Effect Purity
  • HY-17367A
    Atazanavir sulfate Inhibitor 99.64%
    Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor.
  • HY-15148
    Tipranavir Inhibitor 99.54%
    Tipranavir inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM.
  • HY-90001
    Ritonavir Inhibitor 99.55%
    Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
  • HY-17041
    Darunavir Ethanolate Inhibitor 99.73%
    Darunavir ethanolate (TMC114 ethanolate) is a potent HIV protease inhibitor used to treat and prevent HIV/AIDS.
  • HY-17007
    Saquinavir Inhibitor 99.71%
    Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
  • HY-15287
    Nelfinavir Inhibitor
    Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.
  • HY-14588
    Lopinavir Inhibitor 99.58%
    Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.
  • HY-15287A
    Nelfinavir Mesylate Inhibitor 98.90%
    Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection.
  • HY-17431
    Fosamprenavir Calcium Salt Inhibitor 99.19%
    GW433908 is a phosphate ester prodrug of the antiretroviral protease inhibitor amprenavir, with improved solubility over the parent molecule and a potential for reduced pill burden on current dosing regimens; GW433908G is the calcium salt of the prodrug.
  • HY-B0689A
    Indinavir sulfate Inhibitor 99.50%
    Indinavir sulfate(MK-639 sulfate; L735524 sulfate ) is a potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
  • HY-17003
    Saquinavir Mesylate Inhibitor 99.79%
    Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy.
  • HY-17430
    Amprenavir Inhibitor
    Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection.
  • HY-17040
    Darunavir Inhibitor 99.39%
    Darunavir(TMC114) is an HIV protease inhibitor.
  • HY-19400
    DPC-681 Inhibitor
    DPC-681 is a potent and selective inhibitor of HIV protease with IC90s for wild-type HIV-1 of 4 to 40 nM.
  • HY-B0689
    Indinavir Inhibitor
    Indinavir(MK-639; L735524) is a potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
  • HY-17367
    Atazanavir Inhibitor
    Atazanavir(BMS-232632) is an highly potent HIV-1 protease inhibitor.